Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 6401 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Appointment of Dr Darren Patti to Group Chief Operating Officer

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  Telix Pharmaceuticals Limited

FDA Seeks $7.2 Billion to Enhance Food Safety and Nutrition, Advance Medical Product Safety, and Strengthen Public Health

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  U.S. Food and Drug Administration

The Inner Circle acknowledges Sharon E. Oster, MD, as a Pinnacle Life Member

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Emergency Nurses Report Barriers to Talking with Patients about Serious Illnesses

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Transitioning new clinicians from education to practice named top patient safety concern of 2024

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  ECRI Institute

Neurocrine Biosciences to Participate at Virtual Investor Conferences in March

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  Neurocrine Biosciences, Inc.

American Headache Society Publishes Updated Guidance on Migraine Preventive Therapy

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Johnson & Johnson submits supplemental Biologics License Application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

FSA Store® Shares 10 Ways to Support Spring Healthcare Needs and Use Flexible Spending Account (FSA) Funds Before the March 15 Grace Period Deadline

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  DaVita Inc.

World Vaccine Congress Draws Leaders from Government, Science and Industry

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

AANA Advocates for Excellence During Patient Safety Awareness Week

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  Akebia Therapeutics, Inc.

Cardiovascular Infection on the Rise: New Multisociety Statement Defines Appropriate Use of PET/CT and SPECT/CT for Evaluation

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

BLUE SHIELD OF CALIFORNIA and ZÓCALO RAISING AWARENESS OF COLORECTAL CANCER, WITH SCREENINGS AND HEALTH EDUCATION

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Digital Health Regulations Analysis: Strategic Insights into North America and Europe's Growth Opportunities

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  enGene Holdings Inc.

Cell Impact has received an order worth SEK 18 million in the field of electrolysis

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Lexicon Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑